- Proteomics International (PIQ) has won a major pharmacokinetic testing contract with Australia’s largest clinical trial contract research organisation, Avance Clinical
- Pharmacokinetics is the study of what happens to drugs once they are inside the body
- The contract between the parties will study a drug for lysosomal storage disorder on behalf of a U.S. pharmaceutical company
- This work expected to undertaken over the next three months
- Notably, this contract valued at $243,000 — making it Proteomics largest to date
- Proteomics ended the day down 0.44 per cent to close at $1.14 per share
